Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1
      Description

      The primary purpose of this study is to evaluate the safety, tolerability and effectiveness of encaleret in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

      Conditions
      Autosomal Dominant Hypocalcemia (ADH)Autosomal Dominant Hypocalcemia Type 1 (ADH1)
      Talk to us
      ACTIVE_NOT_RECRUITING
      Efficacy and Safety of Encaleret Compared to Standard of Care in Participants with ADH1
      Description

      The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

      Conditions
      Autosomal Dominant Hypocalcemia (ADH)
      Talk to us
      ACTIVE_NOT_RECRUITING
      ADH1 and ADH2 Disease Monitoring Study (DMS)
      Description

      A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.

      Conditions
      Autosomal Dominant Hypocalcemia
      Talk to us